Interferon-alpha-carboplatin combination therapy for metastatic melanoma: phase II study

Eur J Cancer. 1994;30A(14):2182-3. doi: 10.1016/0959-8049(94)00359-d.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Letter

MeSH terms

  • Adult
  • Aged
  • Carboplatin / therapeutic use*
  • Combined Modality Therapy
  • Female
  • Humans
  • Interferon-alpha / therapeutic use*
  • Male
  • Melanoma / therapy*
  • Middle Aged
  • Neoplasm Metastasis

Substances

  • Interferon-alpha
  • Carboplatin